Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Cardiothoracic surgeons with UofL Health – Jewish Hospital and the University of Louisville performed the world’s first Carmat Aeson bioprosthetic total artificial heart implantation in a female patient on Sept. 14, 2021. The device was small enough to fit into the woman's smaller chest cavity. The device is being tested as a bridge to heart transplant rather than use of a LVAD. Photo by UofL Health.

News | Heart Failure

First Woman in World Receives New Type of Artificial Heart

September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has performed ...

September 22, 2021

News | Heart Failure

ESC Releases Guidelines on Heart Failure Management

September 21, 2021 — The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and ...

September 21, 2021

$Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology, which are transcatheter devices used to seal brain aneurysms. The company said there is a risk of the delivery system’s wire and tubes fracturing and breaking off when the system is being used to place, retrieve, or move the stent inside a patient.$

News | Cath Lab

Medtronic Recalls Neurovascular Pipeline Flex Embolization Devices for Risk of Fractures During Placement, Retrieval or Movement of Device

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device ...

September 21, 2021

Videos | Structural Heart

VIDEO: Abbott Structural Heart Technology Advances in 2021

Dr. Neil Moat, MBBS, chief medical officer of Abbott's structural heart business, explains the latest advances in Abbott ...

September 20, 2021

The U.S. Food and Drug Administration (FDA) has cleared the company's Portico with FlexNav transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.

Feature | Structural Heart Occluders | By Dave Fornell, Editor

FDA Clears Abbott Portico TAVR System to Treat Aortic Valve Disease

September 20, 2021 — Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Portico ...

September 20, 2021

Videos | Congenital Heart

VIDEO: The Heart Team Approach in Congenital Structural Heart Interventions

Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the heart team ...

September 15, 2021

MedAxiom conducetd a survey of hospitals that offer cardiac rehab, cardiovascular rehabilitation, programs to find out the costs, how they are staffed and how they are implemented.

News | Cardiac Rehabilitation

MedAxiom Survey Highlights Cardiac Rehab Industry Insights and Best Practices

September 14, 2021 – MedAxiom, an American College of Cardiology (ACC) company, released a report detailing cardiac ...

September 14, 2021

Non-invasive evaluation of heart valves using echocardiography first, and other cardiac imaging techniques when needed, is the key evaluation of heart valves in the new ESC and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease. Photo by Dave Fornell.

News | Structural Heart

New European Guidelines on Valvular Heart Disease Published

September 13, 2021 — The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery ...

September 13, 2021

A nurse at Banner Health ion Phoenix, Ariz., adjusts an ECMO unit being used to support a severely ill COVID-19 patient. A new study finds high levels of moral distress among clinicians who regularly care for patients receiving mechanical circulatory support such as ECMO.

News | ECMO Systems

Growing Use of Mechanical Circulatory Support Affects Clinician Well-Being, Moral Distress

September 13, 2021 — The growing use of mechanical circulatory support (MCS) may contribute to high levels of moral ...

September 13, 2021

Siemens Artis Q angiography system #ESC #ESCcongress

News | Sudden Cardiac Arrest

TOMAHAWK Trial Does Not Support Early Coronary Angiography in Cardiac Arrest Without ST-elevation

September 13, 2021 — Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment ...

September 13, 2021

COVID in cardiology was again a key driver of content pageviews on DAIC in August 2021. Also, a key new technology that cardiologists had a lot of interest in was the release of 3D/4D intra-cardiac echocardiography (ICE) to better guide EP and structural heart procedures without the need for transesophageal echo and its associated need for deep anesthesia.

Feature | By Dave Fornell, Editor

September 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

September 03, 2021

Drones Could Deliver Defibrillators or AEDs to sudden Cardiac Arrest Victims Faster Than Ambulances. Getty Images

Feature | Sudden Cardiac Arrest

Drones Could Deliver Defibrillators to Cardiac Arrest Victims Faster Than Ambulances

September 1, 2021 — The world’s first feasibility study has found that drones can be used to deliver life-saving defibri ...

September 01, 2021

The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with AFib who undergo transcatheter aortic valve replacement (TAVR), according to an ESC late-breaking trial.

News | Antiplatelet and Anticoagulation Therapies

Edoxaban May Be Effective Treatment for Atrial Fibrillation After TAVR

September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart ...

September 01, 2021

The Stereotaxis Genesis EP robotic navigation system.

News | EP Lab

Stereotaxis and Microport EP Partner to Commercialize Electrophysiology Robotics in China

September 1, 2021 — Stereotaxis and Shanghai Microport EP Medtech Co., Ltd. announced a broad collaboration to advance ...

September 01, 2021

Videos | Cardiovascular Information Systems (CVIS)

VIDEO: Example of Epsilon Strain Imaging Deep Integration With Siemens CVIS

One of the trends in cardiovascular information system (CVIS) and radiology PACS at the Healthcare Information ...

August 31, 2021